June Goto, PhD
Affiliations: | 2007-2012 | Translational Medicine | Harvard University, Cambridge, MA, United States |
| 2013- | Pediatric Neurosurgery | Cincinnati Children's Hospital and Medical Center |
Area:
cortical development, TSC, hydrocephalusGoogle:
"June Goto"Mean distance: 106866
Parents
Sign in to add mentor| Tadashi Yamamoto | grad student | 2000-2006 | University of Tokyo |
| David J. Kwiakowski | post-doc | 2007-2012 | Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goulding DS, Vogel RC, Pandya CD, et al. (2020) Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice. Journal of Neurosurgery. Pediatrics. 1-8 |
| Emmert AS, Iwasawa E, Shula C, et al. (2019) Impaired neural differentiation and glymphatic CSF flow in the rat model of neonatal hydrocephalus: genetic interaction with . Disease Models & Mechanisms. 12 |
| Emmert AS, Vuong SM, Shula C, et al. (2019) Characterization of a novel rat model of X-linked hydrocephalus by CRISPR-mediated mutation in L1cam. Journal of Neurosurgery. 1-14 |
| Abdelhamed Z, Vuong SM, Hill L, et al. (2018) A mutation in Ccdc39 causes neonatal hydrocephalus with abnormal motile cilia development in mice. Development (Cambridge, England). 145 |
| Hu Z, Wang Y, Huang F, et al. (2015) Brain Expressed X-Linked 2 Is Pivotal for Hyperactive mTOR-Mediated Tumorigenesis. The Journal of Biological Chemistry |
| Prabhakar S, Zhang X, Goto J, et al. (2015) Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. Neurobiology of Disease. 82: 22-31 |
| Prabhakar S, Zhang X, Goto J, et al. (2015) 196. AAV-Mediated Gene Replacement Therapy in Mouse Model of Tuberous Sclerosis Molecular Therapy. 23 |
| Prabhakar S, Goto J, Zhang X, et al. (2013) Stochastic model of Tsc1 lesions in mouse brain. Plos One. 8: e64224 |
| Goto J, Talos DM, Klein P, et al. (2011) Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proceedings of the National Academy of Sciences of the United States of America. 108: E1070-9 |
| Anderl S, Freeland M, Kwiatkowski DJ, et al. (2011) Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex. Human Molecular Genetics. 20: 4597-604 |